Xtant Medical Holdings, Inc. (XTNT) Financial Statements
Industry: Surgical & Medical Instruments & Apparatus
In fiscal 2025, Xtant Medical reported revenue of $133.9M, up 14.2% from $117.3M the year before. Net income was $5.0M (a 3.7% net margin), or $0.03 per diluted share. Gross margin was 62.9% and operating margin was 5.4%. Operating activities generated $12.5M of cash, leaving $10.2M of free cash flow. At fiscal year end, Xtant Medical held $94.1M in total assets against $43.2M in total liabilities, including $17.1M of cash and equivalents.
Open the full interactive Xtant Medical financials → Quarterly statements, key ratios, valuation history and price charts.
Xtant Medical Key Stats
| Share Price | $0.32 |
|---|---|
| Market Cap | $44.9M |
| P/E Ratio | 10.7 |
| Revenue YoY Growth | +14.2% |
| 52-Week Range | $0.31 – $0.92 |
| Shares Outstanding | 140.3 million (basic, 2026 Q2) |
Xtant Medical Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $53.3M | $55.3M | $58.0M | $91.3M | $117.3M | $133.9M |
| Cost of Goods Sold | $18.9M | $22.8M | $25.8M | $35.8M | $49.1M | $49.7M |
| Gross Profit | $34.4M | $32.5M | $32.1M | $55.5M | $68.2M | $84.3M |
| Operating Income | -$751,000 | -$3.9M | -$6.8M | -$10.2M | -$12.1M | $7.3M |
| Pre-Tax Income | -$6.7M | -$4.8M | -$8.4M | -$1.0M | -$16.3M | $7.0M |
| Income Tax | $296,000 | — | $69,000 | -$1.7M | $187,000 | $2.0M |
| Net Income | -$7.0M | -$4.8M | -$8.5M | $660,000 | -$16.4M | $5.0M |
| Diluted EPS | -$0.25 | -$0.06 | -$0.09 | $0.01 | -$0.12 | $0.03 |
Xtant Medical Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $33.3M | $32.4M | $20.9M | $23.0M |
| Net Income | $1.3M | $57,000 | -$3.1M | -$9.4M |
| Diluted EPS | $0.01 | $0.00 | -$0.02 | -$0.07 |
Xtant Medical Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $2.3M | $18.2M | $20.3M | $5.7M | $6.2M | $17.1M |
| Current Assets | $31.4M | $44.3M | $49.3M | $64.9M | $67.1M | $78.2M |
| Total Assets | $41.5M | $54.7M | $60.2M | $92.6M | $93.8M | $94.1M |
| Current Liabilities | $25.6M | $11.1M | $15.2M | $23.0M | $28.6M | $29.5M |
| Total Long-Term Debt | $16.8M | $11.8M | $12.0M | $17.2M | $22.0M | $14.5M |
| Total Liabilities | $27.0M | $23.8M | $26.1M | $41.3M | $50.9M | $43.2M |
| Shareholders' Equity | $14.5M | $30.9M | $34.2M | $51.3M | $43.0M | $51.0M |
Xtant Medical Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$731,000 | $439,000 | -$5.3M | -$9.5M | -$11.9M | $12.5M |
| Cash From Investing | -$1.3M | -$1.9M | -$1.6M | -$24.8M | -$3.7M | $7.9M |
| Cash From Financing | -$861,000 | $17.5M | $9.0M | $19.7M | $16.1M | -$9.6M |
| Free Cash Flow | -$2.3M | -$1.7M | -$7.1M | -$11.0M | -$16.0M | $10.2M |
Figures from Xtant Medical's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Xtant Medical financials page for every line item.
Xtant Medical Company Profile
| Ticker | XTNT |
|---|---|
| Exchange | NYSE |
| Industry | Surgical & Medical Instruments & Apparatus |
| Headquarters | Belgrade, Montana |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Non-accelerated filer, smaller reporting company |
| SEC CIK | 0001453593 |
Frequently Asked Questions
What was Xtant Medical's revenue in fiscal 2025?
Xtant Medical (XTNT) reported revenue of $133.9M for fiscal 2025.
What is Xtant Medical's annual revenue history?
Xtant Medical's annual revenue by fiscal year: 2020: $53.3M; 2021: $55.3M; 2022: $58.0M; 2023: $91.3M; 2024: $117.3M; 2025: $133.9M.
What was Xtant Medical's net income in fiscal 2025?
Xtant Medical reported net income of $5.0M for fiscal 2025.
What was Xtant Medical's earnings per share (EPS) in fiscal 2025?
Xtant Medical's diluted EPS was $0.03 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Xtant Medical generate in fiscal 2025?
Xtant Medical generated $10.2M of free cash flow in fiscal 2025.
What was Xtant Medical's revenue last quarter?
In its most recent reported quarter (2026 Q2), Xtant Medical reported revenue of $23.0M.
How much debt does Xtant Medical have?
Xtant Medical reported $14.5M of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of Xtant Medical are outstanding?
Xtant Medical reported a weighted average of 140.3 million basic shares outstanding in 2026 Q2.
What is Xtant Medical's market cap?
Based on its latest closing price, Xtant Medical (XTNT) has a market capitalization of about $44.9M.
When does Xtant Medical's fiscal year end?
Xtant Medical's fiscal year end, as registered with the SEC, is December 31.
Where is Xtant Medical headquartered?
Xtant Medical lists its business address in Belgrade, Montana in its SEC filings.